Weigao (1066) and Weigao Orthopaedic (688161) Release Overseas Regulatory Announcement

Bulletin Express02-27

Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited have noted that Shandong Weigao Group Medical Polymer Company Limited (1066) issued an overseas regulatory announcement dated 27 February 2026. The announcement emphasizes that the organizations accept no responsibility for its content while requiring compliance with the relevant listing rules.

According to pertinent regulations of the People’s Republic of China, Shandong Weigao Orthopaedic Device Company Limited (688161) has published its announcement on the Shanghai Stock Exchange’s website. The disclosure indicates that an update is available in Chinese, and it has been released in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

The board of directors of Shandong Weigao Group Medical Polymer Company Limited comprises Executive Directors Long Jing, Cong Rinan, Lu Junqiang, and Wang Daoming; Non-executive Directors Chen Lin and Tang Zhengpeng; and Independent Non-executive Directors Li Guohui, Meng Hong, Li Qiang, and Sun Heng.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment